Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators
Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy
Yayımlanan kategori: World
Daha fazla WorldWorld kategorisinden daha fazla yazı »
- Hong Kong judge rules in favor of transgender bathroom access
- ‘Return to the dark days’: Protests take aim at Zelensky for first time in the war
- New York realtor gets banned from Columbia for 10 years after violent airport tirade
- Army secretary wants to move more quickly on an agreement for Hawaii live-fire training lands
- Appeal date set for convicted high country killer Greg Lynn
İlk yorum yapan siz olun